2. Relapsed/Refractory MCL: Patient has relapsed and or refractory MCL and must have received at least one prior treatment regimen for their disease. Patient with leukemia phase (peripheral blood involvement), leptomeningeal disease, cerebral spinal fluid (CSF) MCL, central nervous system (CNS) MCL, non-measurable disease, gastrointestinal (GI) MCL, or bone marrow (BM) MCL are also eligible.